Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)
Price and Volume
Detailed Quote| Volume | 1,502,814 |
| Open | 93.64 |
| Bid (Size) | 87.11 (100) |
| Ask (Size) | 102.68 (100) |
| Prev. Close | 93.04 |
| Today's Range | 90.79 - 93.64 |
| 52wk Range | 61.23 - 134.00 |
| Shares Outstanding | 142,334,900 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
52-Week Range
31.8% below 52-week high
91.35
61.2352W Low
134.0052W High
1 Week
10.2% below 1-week high
90.791W Low
101.751W High
Halozyme Therapeutics, Inc. - Common Stock (HALO) traded between $61.23 and $134.00 over the past 52 weeks and last traded at $91.35, 31.8% below its 52-week high. Over the past week it ranged between $90.79 and $101.75.
Past 12 Months
1W
-$5.15
1M
-$33.48
3M
-$16.82
6M
+$23.03
YTD
+$21.04
1Y
+$22.38
HALO was +32.4% over the past year, +33.7% over six months, +29.9% year to date, -5.3% in the last week.
12 Months vs Market
HALO
+32.4%
DIA
+5.0%
SPY
+5.7%
QQQ
+3.9%
IWM
+12.0%
Over the past 12 months HALO returned +32.4% versus DIA (Dow) +5.0%, SPY (S&P 500) +5.7%, QQQ (Nasdaq 100) +3.9% and IWM (Russell 2000) +12.0%.
Volume & Liquidity
0.66× 3-mo avg
Today 1,502,814
3-mo avg 2.3M
1W
2.2M
1M
2.4M
3M
2.3M
6M
2.2M
YTD
2.0M
1Y
2.0M
HALO most recently traded 1,502,814 shares against a 3-month average daily volume of 2.3M.
More News
Read More
What Halozyme Therapeutics (HALO) Said on Its Q3 Earnings Call ↗
November 06, 2026
2 Reasons to Like HALO (and 1 Not So Much)
October 19, 2026
1 Unpopular Stock That Deserves a Second Chance and 2 We Brush Off
October 13, 2026
Biogen (NASDAQ:BIIB) Q2 Earnings: Leading The Therapeutics Pack
September 24, 2026
1 Cash-Producing Stock to Target This Week and 2 We Question
September 22, 2026
1 Mid-Cap Stock on Our Watchlist and 2 We Avoid
August 31, 2026
3 Market-Beating Stocks for Long-Term Investors
August 28, 2026
1 Healthcare Stock with Exciting Potential and 2 We Avoid
August 27, 2026
2 Mid-Cap Stocks with Solid Fundamentals and 1 Facing Challenges
August 24, 2026
Halozyme (HALO) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
Frequently Asked Questions
Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 91.35
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 11/20/26 04:00 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 13.00B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 13B shares outstanding.